Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: Doximity | Vintage Vibes

Doximity Q4 Earnings Call Highlights

Doximity (NYSE:DOCS) reported fiscal fourth-quarter revenue above the high end of its guidance and said it is entering what management called an “AI investment year,” with higher spending planned for artificial intelligence products even as near-term growth in the digital pharma advertising market r

Can Waystar Still Stand Up to Rising Competition?

Can Waystar Still Stand Up to Rising Competition?

Companies at the intersection of cloud or AI technology and healthcare have underperformed in the last year, but some firms have compelling cases for buyers.

3 New Year’s Resolution Stocks That Could Turn Around in 2026

3 New Year’s Resolution Stocks That Could Turn Around in 2026

Three companies with less-than-stellar performance records in 2025 may have the fundamentals needed to reverse course in the new year.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings

Doximity Inc (NYSE:DOCS) reported better-than-expected earnings for the first quarter on Thursday.

Analyst Ratings For Doximity

Ratings for Doximity (NYSE:DOCS) were provided by 15 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

A burnout crisis is hitting doctors across the U.S. and it could spell disaster for health care

Pay increased nearly 6% in 2023—not enough to account for inflation and low reimbursements, found Doximity.

Looking At Doximity's Recent Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bullish stance on Doximity. Looking at options history for Doximity (NYSE:DOCS) we detected 18 strange trades.

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022

Peering Into Doximity's Recent Short Interest

Peering Into Doximity's Recent Short Interest

Doximity's (NYSE:DOCS) short percent of float has risen 3.27% since its last report. The company recently reported that it has 7.21 million shares sold short, which is 8.22% of all regular shares that are available for trading.

Looking At Doximity's Recent Whale Trades

Looking At Doximity's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Doximity (NYSE:DOCS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Why Doximity Stock Is Falling Today

Why Doximity Stock Is Falling Today

Doximity Inc (NYSE: DOCS) shares are trading lower Wednesday after the company reported financial results and issued quarterly guidance below analyst estimates.

What 5 Analyst Ratings Have To Say About Doximity

What 5 Analyst Ratings Have To Say About Doximity

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Why Doximity Shares Are Trading Lower After Hours

Why Doximity Shares Are Trading Lower After Hours

Doximity Inc (NYSE:DOCS) reported fourth-quarter revenue growth of 40.4% year-over-year to $93.7 million, beating the consensus of $90.11 million. Adjusted net income was $44.9 million versus $24 million in 4Q21, representing a 48% margin. Adjusted EPS was $0.21, beating the consensus of $0.15. Adjusted gross margin expanded by 200 bps to 90%.…

Get all your
news in one place.

100's of premium titles.
One news app.

Where Doximity Stands With Analysts

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Where Doximity Stands With Analysts

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Why Doximity Shares Are Trading Higher Premarket Today?

Doximity Inc (NYSE: DOCS) posted Q3 FY22 sales of $9

1

People

Stephanie Davis

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

B of A Securities

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

382,161 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play